Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Goldman Sachs Group    GS

GOLDMAN SACHS GROUP (GS)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Morgan Stanley trader was probed at Goldman: sources

share with twitter share with LinkedIn share with facebook
share via e-mail
0
12/04/2012 | 12:07am CEST
The headquarters of Morgan Stanley is seen in New York

(Reuters) - Morgan Stanley hired former Goldman Sachs trader Edward Glenn Hadden to run its Treasury bond desk last year, even though his former employer had placed the trader on paid leave for about a year following an internal inquiry, said three people familiar with the situation.

The inquiry by Goldman involved a matter separate from an ongoing investigation by exchange operator CME Group into a December 2008 trade that involved U.S. Treasury futures.

Neither Hadden nor Goldman has been accused of wrongdoing in the 2008 trading incident. But the decision by Morgan Stanley to hire Hadden even though some of his activities had raised questions within Goldman could put the firm in an uncomfortable position in light of the revelations of the CME Group investigation.

Hadden was a partner at Goldman Sachs when the 2008 trade drawing scrutiny occurred. The incident that led to the Goldman internal inquiry took place the end of 2009 and involved profits Hadden is said to have made ahead of the launch of a new Treasury futures contract introduced by the CME Group in early 2010.

Morgan Stanley and Goldman Sachs both recently learned of the CME investigation into the 2008 incident. But sources said Morgan Stanley was aware Goldman had put Hadden on paid leave when it hired him in March 2011.

Hadden's lawyer said his client did nothing wrong with the 2008 trade and expects the CME to reach a similar conclusion when it completes its investigation.

"There is no legal or factual basis for any suggestion of market manipulation," said James Benjamin, who defended his client in response to a recent regulatory disclosure by the firm that Hadden is being investigated by CME over a 4-year-old trade.

Benjamin had no comment about the incident that led to Goldman putting Hadden on paid leave that effectively barred him from trading at the firm for about a year.

Hadden, who goes by his middle name "Glenn," officially left Goldman (>> Goldman Sachs Group, Inc.) in late 2010. A few months later, Hadden, who had been a partner at Goldman, joined Morgan Stanley with much fanfare to run the Wall Street firm's Treasury bond and interest rate derivatives trading desk.

Hadden is one of the most successful traders in the market for Treasury bonds and interest rate derivatives, whose value stands at $531.6 trillion, according to the Securities Industry and Financial Markets Association. He had worked for Goldman Sachs for about 11 years before voluntarily leaving the firm at the end of 2010.

Trading in Treasuries and interest rate derivatives is an important part of Morgan Stanley's bond trading business, as it focuses on high-volume trading that can be easily automated and cleared under new regulations, rather than riskier and more complex over-the-counter trades.

Benjamin, a defense attorney with Akin Gump, said the CME investigation involves a "technical risk management activity" that occurred "in a one-minute period four years ago." While Benjamin declined to discuss the specifics of the allegation against Hadden in his statement, the lawyer said his client had "acted properly and followed established market practice."

CME Group declined to comment.

Morgan Stanley spokesman Mark Lake said Hadden is still employed by the firm, and in good standing.

News of the investigation broke on Sunday evening when The New York Times posted a story on its website about Hadden with the headline "Morgan Stanley Trader Faces Inquiry on Possible Manipulation."

The paper, citing a regulatory filing and sources familiar with the matter, said the CME was investigating Hadden over whether his Treasury futures trading had manipulated prices.

Hadden's file with the Financial Industry Regulatory Authority cites a pending CME investigation of his Treasury futures orders placed on the expiration date in December 2008.

The trades being probed by the CME pertained to programs set up by the Federal Reserve during the height of the financial crisis to help support Wall Street and the banking system, a person familiar with the matter said.

The New York Times reported that some at the Fed had suspected that Goldman was trying to improperly profit from one of the government's bond-buying programs, and complained to Goldman about Hadden.

The 2009 incident that led to the Goldman internal inquiry also involved Treasury futures but had nothing to do with the U.S. government's efforts to prop up the financial system.

Instead, the 2009 matter involved a new Treasury futures trading product the CME was developing and one which Hadden had advised on, said those people, who were not authorized to speak publicly on the matter.

Hadden had found a way to structure a Treasury trade ahead of the CME's official announcement in September 2009 that it was going to launch in early 2010.

That incident moved his superiors at Goldman to put him on leave, keeping him on the payroll but preventing him from actively trading for about a year.

Indeed, even as the CME investigates Hadden over the 2008 incident, its product development team has continued to turn to him for help in devising new Treasury futures products. CME Group quoted Hadden in a September 18 press release highlighting a new interest rate swap futures product.

(Reporting by Lauren Tara LaCapra and Emily Flitter; Additional reporting by Ann Saphir; Editing by Matthew Goldstein, Steve Orlofsky, Leslie Gevirtz and Richard Chang)

By Lauren Tara LaCapra and Emily Flitter

Stocks treated in this article : CME Group Inc, Goldman Sachs Group, Inc., Morgan Stanley
Stocks mentioned in the article
ChangeLast1st jan.
CME GROUP -0.32% 161.08 Delayed Quote.10.29%
GOLDMAN SACHS GROUP -1.34% 239.23 Delayed Quote.-3.18%
MORGAN STANLEY -1.94% 52.04 Delayed Quote.1.14%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on GOLDMAN SACHS GROUP
11:36aDEUTSCHE BANK : scales back investment bank as profit drops
RE
11:36aDEUTSCHE BANK : scales back investment bank as profit drops
RE
11:34aDEUTSCHE BANK : scales back investment bank as profit drops
RE
04/25U.S. Bank Regulator Acquired Bank Stock While Nomination Was Under Review -- ..
DJ
04/25U.S. Bank Regulator Acquired Bank Stock While Nomination Was Under Review
DJ
04/25Global banks fear China will limit JV control through new rules
RE
04/24AZZ Incorporated Position Cut by Metropolitan Life Insurance Co. NY
AQ
04/24LSE's income rises as row over CEO departure fades
RE
04/24CityFibre agrees $750 million takeover by Goldman Sachs consortium
RE
04/24GOLDMAN SACHS : Global insurers plan to ramp up private equity investments - Gol..
RE
More news
News from SeekingAlpha
04/23Goldman hires cryptocurrency head 
04/20Vilas Fund, LP Q1 '18 Letter To Partners - #28 Since Inception, Long Pharma 
04/20PORTFOLIO STRATEGY REPORT : Why Investors Should Build Shares In Bioscience Stoc.. 
04/20Goldman Sachs Offers Attractive Entry Point For Buy And Hold Investors 
04/19Flattening Yield Curve, Trade Tensions, Kinder Morgan (Wall Street Breakfast .. 
Financials ($)
Sales 2018 35 327 M
EBIT 2018 12 217 M
Net income 2018 9 032 M
Debt 2018 -
Yield 2018 1,34%
P/E ratio 2018 10,41
P/E ratio 2019 9,88
Capi. / Sales 2018 2,60x
Capi. / Sales 2019 2,56x
Capitalization 91 911 M
Chart GOLDMAN SACHS GROUP
Duration : Period :
Goldman Sachs Group Technical Analysis Chart | GS | US38141G1040 | 4-Traders
Technical analysis trends GOLDMAN SACHS GROUP
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 28
Average target price 272 $
Spread / Average Target 14%
EPS Revisions
Managers
NameTitle
Lloyd Craig Blankfein Chairman & Chief Executive Officer
David Michael Solomon President & Chief Executive Officer
R. Martin Chavez Chief Financial Officer & Executive Vice President
James A. Johnson Independent Director
William W. George Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
GOLDMAN SACHS GROUP-3.18%91 911
MORGAN STANLEY1.14%94 143
CHARLES SCHWAB6.07%73 463
CITIC SECURITIES5.75%35 095
NOMURA HOLDINGS INC-5.17%21 384
HUATAI SECURITIES6.78%19 113